Key Takeaways
- Revenue doubled, margins compressed: Revenue hit a record ₹612.4 Cr, up 115.9% YoY, but EBITDA margin fell ~300 bps as lower-margin imports filled the demand gap that maxed-out own production could not serve.
- Imports are a structural margin diluter, not a one-off: Own manufacturing delivers 13–14% EBITDA; imported NPK variants yield just 2.5–3%. With plants at 100% utilisation, all incremental demand flows through the lower-margin import channel, pulling blended margins down.
- Two capacity projects are nearing the finish line: Sagar expansion shifts to Q1 FY27 (trial runs March), and Dhule Phase 1 targets commercial production from October 2026. Together they promise to shift the mix back toward own manufacturing.
- FY27 revenue ambition is bold and backable: Management guides for >50% revenue growth in FY27, underpinned by the Dhule ramp; the plant alone carries a potential of ₹2,000 Cr+ in revenue at conservative utilisation.
- What to watch next quarter: Whether Sagar trials succeed in April, the trajectory of the import-to-own-production mix, and any clarity on the unexplained Q3 EBITDA-per-tonne jump that management could not reconcile on the call.
The Import-Led Margin Story
- Blended margin walk: Own-manufacturing EBITDA held at 13–14%, but imported NPK variants (2.5–3% EBITDA) dragged the blended margin from ~14% to ~11%. The company imports because it currently produces only 20:20:0:13 alongside SSP, while farmer demand for other NPK variants is strong and growing.
- The capacity ceiling: Both SSP and NPK/DAP plants ran above 100% utilisation in Q3 (109% and 115% respectively). With no headroom left, every additional rupee of revenue must come from imports, making margin dilution a function of demand strength.
- Material cost optics: Material cost rose ~200% YoY in absolute terms, but as a percentage of revenue it moved from 90–91% in Q2 to ~95% in Q3. Excluding import content, the ratio is stable; the shift reflects the higher pass-through nature of traded goods.
- Q4 margin outlook: Management expects the same structure to continue: manufacturing EBITDA in the 13–15% range, imported fertiliser EBITDA at ~6%. When an analyst noted this means earnings momentum will lag business momentum, management agreed without offering a timeline for mix improvement.
- Import as market seeding: Imports serve a strategic purpose beyond filling demand: they establish the company's presence in South India so that when Dhule comes online, the market is already built.
Pukhraj Kanther: "Imported fertilizers typically yield returns of about 2.5% to 3%, whereas our own manufactured products generate EBITDA margins of around 13% to 14%. As a result, margins were impacted during the quarter."
Capacity Expansion: The Mix-Repair Catalyst
- Sagar, MP (Banda): DAP/NPK capacity expanding by 90,000 MT plus sulfuric acid. Civil work is complete, plant and machinery orders are placed with equipment in transit. Trial runs expected in March, with commercial production targeted for the first week of April; management allows that it could shift a month either way.
- Dhule, Maharashtra (Phase 1): An integrated complex with 3.3 LMT DAP/NPK, 3.3 LMT SSP, and backward integration into phosphoric and sulfuric acid. Trial production is expected from July 2026, with commercial output from October 2026. Management expressed full confidence in the timeline.
- Post-Dhule scale: Once Dhule is operational, the company will rank fourth in India by phosphatic/complex fertiliser manufacturing capacity. The plant alone carries a revenue potential of more than ₹2,000 Cr, and management flagged that better-than-expected utilisation could push that higher.
- Funding: The Dhule project is being financed through a mix of internal accruals and bank loans.
Pankaj Ostwal: "We are trying for March'26 but as I mentioned in my speech that it is shifting in the 1st Quarter of FY27 commencement of goods."
Revenue Trajectory & Demand Backdrop
- Q3 revenue composition: Of the ₹615 Cr total, ₹335 Cr came from own manufacturing and ₹280 Cr from imports (trading). The import share reflects both demand pull and the strategic seeding effort in South India.
- Q4 momentum: Management expects to sustain similar revenue momentum in the January–March quarter as Q3.
- FY27 growth guide: Revenue is expected to increase by more than 50% in FY27. Own-production momentum is seen continuing through September 2026, after which Dhule begins contributing from October.
- Demand fundamentals: NPK/DAP demand remains very positive, supported by government efforts to expand cultivated area, improve seed quality, and promote balanced nutrition. Management sees no demand concern. Rabi crop coverage exceeded 6.14 crore hectares, up nearly 7 lakh hectares YoY, and advanced estimates for Kharif 2025-26 project record foodgrain production.
- Policy tailwinds: The government approved a 2% increase in NBS subsidy outlay for Rabi 2025-26, an MSP hike for Rabi crops ensuring returns up to 1.5x cost of production, and a National Pulses Mission targeting a sharp increase in pulses output by 2030-31. Enforcement actions against fertiliser diversion and hoarding also support the formal channel.
Operational & Financial Details
- Backward integration utilisation: BRP Crushing at 67%, Sulphuric Acid at 94%, Phosphoric Acid at 50%. The low phosphoric acid utilisation signals room to internalise more raw material as downstream NPK capacity expands.
- Inventory buildup: Finished goods inventories rose due to logistics bottlenecks; railways were prioritising foodgrain movement, delaying fertiliser dispatches. The situation has since normalised and movement is now smooth.
- Working capital: The company consistently maintains current assets at ~45% of annual revenue and proposes to improve this slightly. Temporary deviations may occur due to bulk imports. Subsidy receivables run around two months during season and up to four months in the off-season. All subsidy claims up to the fourth week of November have been received.
- Input prices: Prices have largely remained range-bound except for sulphur, which management described as manageable.
- Unresolved EBITDA-per-tonne question: An analyst flagged that EBITDA per tonne jumped sharply to ~₹6,700–₹6,800 in Q3 from ~₹4,800–₹4,900 in Q2. Management first said it was in line with past trends, then acknowledged the gap could not be that large and requested the analyst to email the exact question for a revert. No on-call explanation was provided.
Strategy & Positioning
- The import logic is deliberate, not accidental: Management frames imports as a dual-purpose tool: meeting demand for NPK variants the company cannot yet produce, and building a market footprint that its own future capacity will serve. Once Dhule is online and the product portfolio diversifies, the South India market will already be established.
- Conservative guidance philosophy: The company deliberately guides conservatively, factoring in potential teething issues at new plants. The ₹2,000 Cr+ revenue potential from Dhule is therefore a base case, with upside if utilisation runs ahead of plan.
- Group-level ambition: Management is actively working to expand capacity across locations and stated that at the group level, the plan is to reach the top of the industry.
Pankaj Ostwal: "This helps us expand our market presence and acts as a seeding operation in the South India market. Once the Dhule plant is operational and if we diversify into other products, the market will already be established."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Own-manufacturing EBITDA margin | Maintain at 13–14% | Ongoing |
| Sagar (Banda) expansion commercial production | 90,000 MT DAP/NPK + sulfuric acid capacity | Q1 FY27 (trial runs March, target early April) |
| Dhule Phase 1 trial production | Integrated SSP, phosphoric acid, NPK complex | July 2026 |
| Dhule Phase 1 commercial production | 3.3 LMT DAP/NPK + 3.3 LMT SSP capacity | October 2026 |
| FY27 revenue growth | More than 50% over FY26 | FY27 |
| Dhule Phase 1 revenue potential | More than ₹2,000 Cr (conservative, at planned utilisation) | From October 2026 ramp |
| Q4 FY26 revenue momentum | Similar to Q3 levels | January–March 2026 |
| Q4 FY26 margin structure | Manufacturing EBITDA 13–15%, imported ~6% | January–March 2026 |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue | ₹612.4 Cr, highest ever, up 115.9% YoY |
| Revenue from manufacturing | ₹335 Cr |
| Revenue from imports | ₹280 Cr |
| EBITDA | ₹66.5 Cr, highest ever, up 68.4% YoY |
| EBITDA margin | 10.9%, down from 14.4% in Q2 FY26 due to higher share of imported fertilizers; own manufacturing EBITDA margin at 13–15% |
| PAT | ₹31.8 Cr, up 77.7% YoY |
| EPS | ₹3.62, vs ₹2.04 in Q3 FY25 |
| Material cost as % of revenue | ~95%, vs 90–91% in Q2 FY26 |
| Fertiliser production volumes | 1,34,355 MT, highest ever |
| Fertiliser sales volumes | 94,958 MT |
| SSP plant utilisation | 109%, production of 65,340 MT |
| NPK/DAP plant utilisation | 115%, production of 69,015 MT |
| Sulphuric acid utilisation | 94% |
| Phosphoric acid utilisation | 50% |
| BRP crushing utilisation | 67% |
| FY26 revenue growth guidance | More than 50% increase expected in FY27, driven by Dhule plant commissioning from October 2026 |